FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance

Jul.30

FDA Commissioner Robert Califf urged the DEA to classify 7-OH, an opioid-like compound found in vapes, drinks, and gummies, as a Schedule I substance. The FDA plans national warnings for doctors and tighter control of high concentrations.

Key points:

·FDA recommends: FDA Commissioner Marty Makary announced that 7-hydroxymitragynine (7-OH) will be classified as a controlled substance due to its opioid-like properties.

·Widespread availability: 7-OH can be found in e-cigarette stores, beverages, and children's gummies.

·Regulatory measures: FDA recommends that 7-hydroxymitragynine above a certain concentration threshold be classified as a Schedule I controlled substance.

·Public education: FDA has issued a report and warned healthcare providers, emphasizing the risks of abuse associated with 7-OH.

【2Firsts News Flash】On July 30th, according to Reuters, Marty Makary, director of the FDA, suggested that 7-hydroxymitragynine (7-OH) be classified as a controlled substance due to its opiate-like properties.

He stated at a press conference held at the Department of Health and Human Services in Washington D.C. that many products containing 7-OH are sold in e-cigarette stores, and this compound is also present in beverages and children's gummy candies.

The FDA's letter to the DEA will recommend classifying 7-OH above a certain concentration threshold as a Schedule I controlled substance.

The FDA stated that the abuse potential of 7-OH is increasingly being scrutinized due to its ability to bind to opioid receptors.

"It is sold in e-cigarette shops, tobacco shops, convenience stores, and gas stations across the United States," said Macari.

The FDA is in the process of releasing a report and sending warning letters to every doctor in America. Markari stated that the FDA will continue its efforts to educate the public.

References:

[1] FDA recommends 7-OH compound found in vapes be controlled

Also Read:

[1] U.S. Fourth Circuit Court Rules North Carolina Can Ban Sale of FDA-Unapproved E-Cigarette Products

[2] U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Korea’s National Assembly Passes Law Classifying E-Cigarettes as Tobacco Products with Full Equivalent Regulation

South Korea’s National Assembly recently passed a comprehensive package of 79 bills that, among other measures, formally classifies liquid vapes — e-cigarette products using nicotine-containing e-liquids — as tobacco products. These products will now be subject to the same taxation, sales restrictions and advertising controls as traditional cigarettes, and the vaping industry in South Korea is expected to face significant adjustments in compliance costs, market access and business strategy.

Dec.03

British Museum Ends Long-Running Sponsorship with Japan Tobacco International

According to The Guardian, the British Museum has ended its 15-year sponsorship with Japan Tobacco International after government inquiries into whether the deal breached WHO tobacco-control rules. Critics had long opposed the partnership, while the museum said sponsorship remains essential for its financial stability and public access.

Nov.20

Russian Police Seize Over 150,000 Counterfeit E-Cigarettes Worth More Than USD 1.65 Million

Russian police in Tambov have detained a man for storing and selling unmarked e-cigarettes. Over 150,000 counterfeit e-cigarettes, cartridges, and e-liquids were seized, valued at more than 126.5 million rubles (approximately USD 1.65 million). Tests revealed that the nicotine content of the seized products exceeded the levels stated on their packaging. A criminal case has been opened under Article 171.1, Part 6 of the Russian Criminal Code.

Dec.09 by 2FIRSTS.ai

Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement

President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.